In its SEC filing, Allena Pharmaceuticals Inc (NASDAQ: ALNA) filed for chapter 11 bankruptcy protection and terminated the employment of substantially all of its employees. In January, the company ...
NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral ...
Kidney stones are on the rise. One cause is a condition called hyperoxaluria – a potentially serious metabolic disorder that’s found in about 20-30 percent of patients with recurrent stones. It that ...
Third Rock Ventures-backed Allena Pharmaceuticals is about to put investors’ renewed appetite for biotech IPOs to the test. Allena arrives on Wall Street armed with data from two phase 2 flops and a ...
NEWTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral ...
NEWTON, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral ...
NEWTON, Mass.--(BUSINESS WIRE)--Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercializing innovative, non-systemic, oral protein therapeutics to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results